Alcohol 2013
DOI: 10.1093/acprof:oso/9780199655786.003.0011
|View full text |Cite
|
Sign up to set email alerts
|

Opioid pharmacogenetics of alcohol addiction

Abstract: Alcohol addiction is one of the most common and devastating diseases in the world. Given the tremendous heterogeneity of alcohol-addicted individuals, it is unlikely that one medication will help nearly all patients. Thus, there is a clear need to develop predictors of response to existing medications. Naltrexone is a m-opioid receptor antagonist, which has been approved in the United States for treatment of alcohol addiction since 1994. It has limited efficacy, in part because of noncompliance, but many patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…take effect through β-endorphin neurotransmitters activating the µ and δ opium receptors [71] . Alcohol takes effect through promoting the reaction of the GABAA receptor [72] and increasing stimulation to the dopamine and opiate receptor [73] , [74] . Nicotine takes effect through acetylcholine neurotransmitters activating the α2β4nACh receptor [75] [77] .…”
Section: Discussionmentioning
confidence: 99%
“…take effect through β-endorphin neurotransmitters activating the µ and δ opium receptors [71] . Alcohol takes effect through promoting the reaction of the GABAA receptor [72] and increasing stimulation to the dopamine and opiate receptor [73] , [74] . Nicotine takes effect through acetylcholine neurotransmitters activating the α2β4nACh receptor [75] [77] .…”
Section: Discussionmentioning
confidence: 99%
“…Given the well-documented interactions between alcohol and the opioid system (Arias & Kranzler, 2008; Berrettini, 2013; Gianoulakis, 2001; Gianoulakis et al, 1989; Job et al, 2007; Oslin, Berrettini, & O’Brien, 2006), we next wanted to assess alcohol use risk in offspring maternally exposed to morphine. The offspring tested in the battery of behavioral tests during adolescence were allowed to mature into adulthood and were then evaluated in an ethanol intermittent two-bottle choice (I2BC) paradigm (Figure 6a), which has been used to assess voluntary ethanol intake (Carnicella et al, 2014; Hwa et al, 2011; Quijano Cardé & De Biasi, 2022; Quijano Cardé et al, 2021).…”
Section: Resultsmentioning
confidence: 99%
“…In fact, the most prominent SNPs that have been linked to alcohol abuse, identified using genome wide association studies (GWAS), have been mapped to genes encoding liver enzymes, specifically alcohol dehydrogenase and aldehyde dehydrogenase (Tawa, Hall, & Lohoff, 2016). However, there are also a number of studies implicating genes that modulate synaptic function such as OPRM1, CHRNA5 and GABRA2 to alcohol abuse as well, suggesting that AUDs have a key neuropsychiatric component that has not been thoroughly investigated (Berrettini, 2013;Hoehe et al, 2000;D. Li et al, 2014;Lubke, Stephens, Lessem, Hewitt, & Ehringer, 2012).…”
Section: Current Work Attempting To Use Ips Cell Technology To Model mentioning
confidence: 99%